BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

According to BTIG Research, value stocks are closing at a 40-year low relative to growth. The primary reason is that ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares ...

BTIG analyst Ryan Zimmerman reiterated a Hold rating on Avita Medical (RCEL – Research Report) today. The company’s shares closed today at ...

BTIG Research has recently reduced Vuzix Corp (VUZI) stock to Neutral rating, as announced on November 10, 2023, according to Finviz. Earlier, on December 21, 2021, Dawson James had initiated the ...

BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...

BTIG Research currently has $40.00 price target on the stock. Several other equities research analysts have also issued reports on ONIT. Keefe, Bruyette & Woods increased their […] ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

BTIG Research’s target price indicates a potential upside of 4.07% from the company’s current price. A number of other brokerages also recently issued reports on REG.

Short seller Hindenburg Research accused Carvana of accounting manipulation and unstable loans. The company denies the ...

BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...